Aβ and tau structure-based biomarkers for a blood- and CSF-based two-step recruitment strategy to identify patients with dementia due to Alzheimer's disease

INTRODUCTION: Alzheimer's disease (AD) diagnosis requires invasive CSF analysis or expensive brain imaging. Therefore, a minimal-invasive reliable and cost-effective blood test is requested to power large clinical AD trials at reduced screening failure. METHODS: We applied an immuno-infrared se...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabers, Andreas, Hafermann, Henning, Wiltfang, Jens, Gerwert, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Special Section: Blood-Based Biomarkers for Alzheimer's Disease & Related Dementias. (Editor: Henrik Zetterberg)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416642/
https://www.ncbi.nlm.nih.gov/pubmed/30911600
http://dx.doi.org/10.1016/j.dadm.2019.01.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416642/
https://www.ncbi.nlm.nih.gov/pubmed/30911600
http://dx.doi.org/10.1016/j.dadm.2019.01.008

Ejemplares similares